ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies
Case Medical Research
◽
10.31525/cmr-24bb59f
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Treatment Option
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
New Treatment
◽
Positive Breast Cancer
Start Chat
Download Full-text
Related Documents
Cited By
References
FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies
Case Medical Research
◽
10.31525/cmr-24bb467
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Treatment Option
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
New Treatment
◽
Positive Breast Cancer
Start Chat
Download Full-text
Beyond trastuzumab: New treatment options for HER2-positive breast cancer
The Breast
◽
10.1016/s0960-9776(11)70289-2
◽
2011
◽
Vol 20
◽
pp. S20-S27
◽
Cited By ~ 34
Author(s):
Kamal S. Saini
◽
Hatem A. Azim
◽
Otto Metzger-Filho
◽
Sherene Loi
◽
Christos Sotiriou
◽
...
Keyword(s):
Breast Cancer
◽
Treatment Options
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
New Treatment
◽
Positive Breast Cancer
Start Chat
Download Full-text
Nanotrastuzumab in combination with radioimmunotherapy: Can it be a viable treatment option for patients with HER2-positive breast cancer with brain metastasis?
Medical Hypotheses
◽
10.1016/j.mehy.2015.12.014
◽
2016
◽
Vol 88
◽
pp. 79-81
◽
Cited By ~ 1
Author(s):
Xuefei Wang
◽
Qiang Sun
◽
Songjie Shen
◽
Yali Xu
◽
Likun Huang
Keyword(s):
Breast Cancer
◽
Brain Metastasis
◽
Treatment Option
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Viable Treatment
◽
Positive Breast Cancer
Start Chat
Download Full-text
Review of treatment strategies for HER2 positive breast cancer and their implementation in a major Swiss hospital
10.1055/s-0040-1710671
◽
2020
◽
Author(s):
F Geissler
◽
M Vetter
◽
A Schoetzau
◽
C Montavon
◽
C Kurzeder
◽
...
Keyword(s):
Breast Cancer
◽
Treatment Strategies
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Start Chat
Download Full-text
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis
10.26226/morressier.596dfd55d462b80292386fa4
◽
2017
◽
Author(s):
You-Jeong Seo
Keyword(s):
Breast Cancer
◽
Neoadjuvant Chemotherapy
◽
Cancer Patients
◽
Sequential Analysis
◽
Breast Cancer Patients
◽
Her2 Positive
◽
Pik3ca Mutations
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Start Chat
Download Full-text
Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines
10.26226/morressier.5b4709836f4cb30010951ad8
◽
2018
◽
Author(s):
Gloria Peiro Cabrera
Keyword(s):
Breast Cancer
◽
Cell Lines
◽
Cancer Cell
◽
Breast Cancer Cell
◽
Breast Cancer Cell Lines
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Id Proteins
◽
Positive Breast Cancer Cell
◽
Positive Breast Cancer
Start Chat
Download Full-text
FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer
Case Medical Research
◽
10.31525/cmr-24bd324
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Start Chat
Download Full-text
Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer
Case Medical Research
◽
10.31525/ct1-nct03847818
◽
2000
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Start Chat
Download Full-text
Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Local Advanced or Metastatic, HER2 Positive Breast Cancer.
Case Medical Research
◽
10.31525/ct1-nct03944499
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Solid Tumors
◽
Phase 1
◽
Advanced Solid Tumors
◽
Her2 Positive
◽
Phase 1 Study
◽
Her2 Positive Breast Cancer
◽
Local Advanced
◽
Positive Breast Cancer
Start Chat
Download Full-text
A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer
Case Medical Research
◽
10.31525/ct1-nct03989037
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Start Chat
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close